News - June 6, 2019

Event 18/09: Performance-Driven Payments in Europe

We would like to make you aware of an event chaired by EUCOPE Secretary General Alexander Natz which looks from various angles at innovative payment models in the UK, BeNeLuxAI, Italy and Germany. Speakers include, inter alia, Dr Diane Kleinermans,… read more

News - May 22, 2019

EMA Regulatory Science Strategy 2025

You still have a bit more than one month to contribute to the EMA’s next strategy for regulatory science! The European Medicines Agency (EMA) is indeed seeking views from stakeholders, partners and the general public on its proposed strategy on… read more

News - April 26, 2019

MAP BioPharma Report on access to OMPs in the UK

Our member MAP BioPharma recently put forward a series of recommendations focused on UK’s appraisals and reimbursement processes, in their latest publication titled Access to Orphan Medicines: A Case for Change. The report shows that: Very small differences between treatments in… read more

News - April 16, 2019

France Biotech HealthTech Investor Day – 24/25 June, Paris

France Biotech, with the help of the European health innovation ecosystem, is organising a HealthTech Investor Day in Paris on 24/25 June 2019. This European business event aims to connect leading investors (European, American and Asian), pharmaceuticals companies and C-level… read more

News - April 1, 2019

EC Gets Ready for a No Deal Brexit

In the event the United Kingdom leaves the EU without a deal, access to medicines may be affected and to alleviate any doubts, the EMA has published a questions & answers document on the preparatory work to prevent medicine shortages…. read more